# US 2023/0397979 A1 · Medical implant for treating aneurysms

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0397979 A1
- Document ID: US20230397979A1
- Status: Published application
- Kind: A1
- Application number: 18/033,757
- Filed: 2021-10-21
- Published: 2023-12-14
- Earliest claimed: 2020-10-26
- Assignees: Acandis GmbH & Co. KG
- Applicants: Acandis GmbH
- Inventors: Michael Büchert; Andreas Schüssler
- Web page: https://patentgrep.com/patent/US20230397979A1

## CPC

- A61F 2/07: Stent-grafts
- A61F 2/856: Single tubular stent with a side portal passage
- A61F 2002/0081: {directly machined on the prosthetic surface, e.g. holes, grooves (A61F2/30771 takes precedence)}
- A61F 2002/068: {Modifying the blood flow model, e.g. by diffuser or deflector}
- A61F 2002/075: {the stent being loosely attached to the graft material, e.g. by stitching}
- A61F 2210/0076: multilayered, e.g. laminated structures
- A61F 2240/001: Designing or manufacturing processes
- A61F 2250/0015: differing in density or specific weight
- A61F 2250/0019: differing in hardness, e.g. Vickers, Shore, Brinell
- A61F 2250/0023: differing in porosity
- A61F 2250/0024: made from both porous and non-porous parts, e.g. adjacent parts
- A61F 2250/0036: differing in thickness
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The disclosure relates to a medical implant for treating aneurysms, including a support structure, which has a compressible and expansible lattice structure lattice elements that define lattice openings, wherein the lattice structure is covered at least in part with an in particular electrospun membrane of fibres, which membrane includes at least one luminal functional layer and at least one abluminal protective layer, which each have pores, wherein the porosity of the functional layer is less than the porosity of the protective layer. The membrane is so configured that at least the pores of the functional layer open, as a result of a pressure gradient arising between a liquid pressure in an inner through channel of the support structure and a liquid pressure outside the protective layer, so as to increase the throughflow of liquid through the membrane.

## Claims

### Claim at position 1

1-18. (canceled)

### Claim 19

A medical implant for treatment of an aneurysm comprising:
a carrier structure having a compressible and expandable mesh structure with mesh elements configured to delimit mesh openings, wherein the mesh structure is covered, at least in one or more sections, with a membrane of fibres including at least one luminal functional layer and at least one abluminal support layer, each layer respectively having pores, wherein a porosity of the functional layer is smaller than the porosity of the support layer, and
wherein the membrane is configured such that, as a consequence of a pressure gradient occurring between a first liquid pressure in an inner through channel of the carrier structure and a second liquid pressure outside the support layer, at least the pores of the functional layer open to increase a flow of liquid through the membrane.

### Claim 20 (depends on 19)

The medical implant according to claim 19, wherein the fibres of the membrane are arranged loosely on top of one another at points of intersection, so that intersecting fibres are movable with respect to each other at the points of intersection, and wherein at least the fibres of the functional layer of the membrane are elastically or plastically deformable.

### Claim 21 (depends on 19)

The medical implant according to claim 19, wherein the fibres of the functional layer of the membrane have a fibre thickness of less than 500 nm and wherein the fibres of the support layer of the membrane have a fibre thickness of at least 500 nm.

### Claim 22 (depends on 19)

The medical implant according to claim 19, wherein the functional layer of the membrane has a thickness of less than 10 μm and wherein the support layer of the membrane has a thickness of at least 3 μm.

### Claim 23 (depends on 19)

The medical implant according to claim 19, wherein the functional layer of the membrane has a porosity of less than 50% and wherein the support layer of the membrane has a porosity of at least 50%.

### Claim 24 (depends on 19)

The medical implant according to claim 19, wherein the functional layer of the membrane comprises at least 10 pores having an inscribed circle diameter of at most 10 μm over a surface area of 100000 μm2, and wherein the support layer of the membrane comprises at least 5 pores having an inscribed circle diameter of at least 10 μm over a surface area of 100000 μm2.

### Claim 25 (depends on 19)

The medical implant according to claim 19, wherein the fibres of the functional layer have a smaller fibre thickness than the fibres of the support layer, and wherein the functional layer has a higher ductility than the support layer or its fibres.

### Claim 26 (depends on 19)

The medical implant according to claim 19, wherein the fibres of the functional layer are formed from a material which has a lower Shore hardness than the material of the fibres of the support layer.

### Claim 27 (depends on 26)

The medical implant according to claim 26, wherein the material of the fibres of the functional layer has a Shore hardness of at most 90A and wherein the material of the fibres of the support layer has a Shore hardness of at least 90A.

### Claim 28 (depends on 19)

The medical implant according to claim 19, wherein the membrane comprises a thermoplastic polyurethane.

### Claim 29 (depends on 19)

The medical implant according to claim 19, wherein the membrane extends around an entire circumference of the carrier structure.

### Claim 30 (depends on 19)

The medical implant according to claim 19, wherein the carrier structure is monolithic in configuration, and wherein the mesh elements of the mesh structure form webs configured to delimit the mesh openings of the mesh structure which are formed as cells.

### Claim 31 (depends on 19)

The medical implant according to claim 19, wherein the carrier structure has interwoven wires, and wherein the wires form the mesh elements of the mesh structure and delimit the mesh openings of the mesh structure which are formed as interstices.

### Claim 32 (depends on 31)

The medical implant according to claim 31, wherein the membrane has a total layer thickness which is at most 40% of a height of the mesh elements.

### Claim 33 (depends on 31)

The medical implant according to claim 31, wherein a height of the mesh elements is between 40 μm and 160 μm.

### Claim 34 (depends on 31)

The medical implant according to claim 31, wherein a ratio between a thickness of the membrane and a height of the mesh elements is at most 1/3.

### Claim 35 (depends on 19)

The medical implant according to claim 19, wherein the functional layer has a perforation in a region of the mesh openings.

### Claim 36 (depends on 35)

The medical implant according to claim 35, wherein the perforation is formed by one of holes, straight slits, curved slits, or T-shaped slits.

### Claim 37

A method for production of a medical implant, the method comprising:
providing a carrier structure having a compressible and expandable mesh structure with mesh elements configured to delimit mesh openings;
applying a luminal functional layer of a membrane of fibres to the carrier structure;
perforating the functional layer by one of a laser cutting process or solvent spraying; and
applying an abluminal support layer of the membrane to the functional layer.
